Safety results from the phase 3 MajesTEC-7 study in patients (pts) with transplant ineligible/not intended newly diagnosed multiple myeloma (NDMM) Meeting Abstract
| Authors: | Touzeau, C.; Beksac, M.; Terpos, E.; Usmani, S. Z.; Krishnan, A. Y.; Nijhof, I. S.; Janowski, W.; Hulin, C.; Grosicki, S.; Delforge, M.; McAleer, D.; Nagle, S.; Olyslager, Y.; Miller, J.; Craig, Z.; Khan, J.; Kampfenkel, T.; Manier, S.; van de Donk, Nwcj |
| Abstract Title: | Safety results from the phase 3 MajesTEC-7 study in patients (pts) with transplant ineligible/not intended newly diagnosed multiple myeloma (NDMM) |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557401735 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.7506 |
| Notes: | Meeting Abstract: 7506 -- Source: Wos |
